Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use
The harmful use of alcohol places a considerable burden on the community, both socially and financially. The aim of this study was to determine if the use of implant naltrexone is associated with a reduction in health care events and costs in patients treated for problematic alcohol use. Ninety four...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Sage Publications
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/33057 |
| _version_ | 1848753839808708608 |
|---|---|
| author | Kelty, E. Hayes, L. O'Neil, G. Kyle, S. Jeffrey, G. O'Neil, G. Hendrie, Delia Mukhtar, Syed Aqif Hulse, G. |
| author_facet | Kelty, E. Hayes, L. O'Neil, G. Kyle, S. Jeffrey, G. O'Neil, G. Hendrie, Delia Mukhtar, Syed Aqif Hulse, G. |
| author_sort | Kelty, E. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | The harmful use of alcohol places a considerable burden on the community, both socially and financially. The aim of this study was to determine if the use of implant naltrexone is associated with a reduction in health care events and costs in patients treated for problematic alcohol use. Ninety four patients (60.6% male) treated between 2002 and 2007 were matched against state hospital, emergency department (ED), mental health out-patients and mortality data sets for 6 months prior to and 6 months post treatment. The number of patients, events, and costs associated with each health event were compared before and after treatment. Overall health care events and costs were reduced from $509033 prior to treatment to $270001 following treatment. Costs associated with hospital admission showed the most significant reduction, falling from $424605 (82 admissions/36 patients) before treatment to $203462 (43 admission/24 patients) after. While costs associated with ED attendances also fell ($74885 to $54712), costs associated with mental health out-patient attendances increased ($9543 to $11827). The use of implant naltrexone was associated with a reduction health events and costs in patients with problematic alcohol use in the first 6 months following treatment. |
| first_indexed | 2025-11-14T08:30:54Z |
| format | Journal Article |
| id | curtin-20.500.11937-33057 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T08:30:54Z |
| publishDate | 2014 |
| publisher | Sage Publications |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-330572017-09-13T15:28:50Z Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use Kelty, E. Hayes, L. O'Neil, G. Kyle, S. Jeffrey, G. O'Neil, G. Hendrie, Delia Mukhtar, Syed Aqif Hulse, G. health services alcohol Naltrexone implant cost The harmful use of alcohol places a considerable burden on the community, both socially and financially. The aim of this study was to determine if the use of implant naltrexone is associated with a reduction in health care events and costs in patients treated for problematic alcohol use. Ninety four patients (60.6% male) treated between 2002 and 2007 were matched against state hospital, emergency department (ED), mental health out-patients and mortality data sets for 6 months prior to and 6 months post treatment. The number of patients, events, and costs associated with each health event were compared before and after treatment. Overall health care events and costs were reduced from $509033 prior to treatment to $270001 following treatment. Costs associated with hospital admission showed the most significant reduction, falling from $424605 (82 admissions/36 patients) before treatment to $203462 (43 admission/24 patients) after. While costs associated with ED attendances also fell ($74885 to $54712), costs associated with mental health out-patient attendances increased ($9543 to $11827). The use of implant naltrexone was associated with a reduction health events and costs in patients with problematic alcohol use in the first 6 months following treatment. 2014 Journal Article http://hdl.handle.net/20.500.11937/33057 10.1177/0269881114536791 Sage Publications restricted |
| spellingShingle | health services alcohol Naltrexone implant cost Kelty, E. Hayes, L. O'Neil, G. Kyle, S. Jeffrey, G. O'Neil, G. Hendrie, Delia Mukhtar, Syed Aqif Hulse, G. Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use |
| title | Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use |
| title_full | Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use |
| title_fullStr | Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use |
| title_full_unstemmed | Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use |
| title_short | Changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use |
| title_sort | changes in hospital and out-patient events and costs following implant naltrexone treatment for problematic alcohol use |
| topic | health services alcohol Naltrexone implant cost |
| url | http://hdl.handle.net/20.500.11937/33057 |